Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
第一作者:
Delong,Chen
第一单位:
Department of Orthopaedic Surgery, Clifford Hospital, Jinan University, Guangzhou 510006, China; School of Biomedical Sciences, University of Western Australia, Perth, Western Australia 6009, Australia.
作者:
医学主题词
动物(Animals);骨密度保护剂(Bone Density Conservation Agents);骨质吸收(Bone Resorption);钙信号(Calcium Signaling);疾病模型, 动物(Disease Models, Animal);女(雌)性(Female);呋喃类(Furans);葡糖苷类(Glucosides);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);丝裂原激活蛋白激酶类(Mitogen-Activated Protein Kinases);NF-E2相关因子2(NF-E2-Related Factor 2);NFATC转录因子类(NFATC Transcription Factors);破骨细胞(Osteoclasts);骨生成(Osteogenesis);骨质疏松(Osteoporosis);卵巢切除术(Ovariectomy);RANK配体(RANK Ligand);活性氧(Reactive Oxygen Species)
DOI
10.1016/j.phrs.2020.104944
PMID
32454224
发布时间
2024-10-24
- 浏览0
Pharmacological research
104944页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



